1
|
Vogel AL, Haynes BM, Hussain SF, Akacem LD, Hodges MG, Duberman JA, Butera G, Faupel‐Badger JM. Areas of strength and opportunities for growth in translational science education and training: Results of a scoping review from the NCATS Education Branch. Clin Transl Sci 2023; 16:1526-1546. [PMID: 37533169 PMCID: PMC10499424 DOI: 10.1111/cts.13570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Revised: 05/18/2023] [Accepted: 05/31/2023] [Indexed: 08/04/2023] Open
Abstract
Translational science education and training (E&T) aims to prepare the translational workforce to accelerate progress along the translational pipeline toward solutions that improve human health. In 2020-2021, the National Center for Advancing Translational Sciences (NCATS) Education Branch conducted a scoping review of the E&T literature with this focus. The review used the methodological framework proposed by Arksey and O'Malley. PubMed, Education Resources Information Center (ERIC), and Embase were searched, and forward citations conducted. Screening of titles, abstracts, and full text identified 44 included articles. Data extraction facilitated analysis of E&T content, audiences, modalities, evaluations, and recommendations. The NCATS Translational Science Principles were used to identity described or recommended E&T content. Twenty-nine articles described a translational science E&T opportunity or its evaluation, and another 15 articles offered recommendations for translational science E&T. The most prevalent NCATS Translational Science Principles were boundary-crossing partnerships (77%) and cross-disciplinary team science (75%). Among publications describing E&T opportunities, the most reported modalities were experiential learning (64%) and courses (61%) and the most reported participants were graduate students (68%) and postdoctoral fellows (54%). About half of these articles (n = 15) reported an evaluation, covering a range of proximal to distal outcomes. Recommendations emphasized the value of translational science E&T across training and career stages and the use of varied modalities to reach diverse audiences. This review highlights strengths and opportunities for growth in translational science E&T. Enhancements to content, expansion of participants and modalities, and rigorous evaluations will contribute to building a highly qualified, diverse translational science workforce.
Collapse
Affiliation(s)
- Amanda L. Vogel
- Education Branch, Office of Policy Communications and EducationNational Center for Advancing Translational Sciences, National Institutes of HealthBethesdaMarylandUSA
| | - Brittany M. Haynes
- Education Branch, Office of Policy Communications and EducationNational Center for Advancing Translational Sciences, National Institutes of HealthBethesdaMarylandUSA
| | - Shadab F. Hussain
- Education Branch, Office of Policy Communications and EducationNational Center for Advancing Translational Sciences, National Institutes of HealthBethesdaMarylandUSA
| | - Lameese D. Akacem
- Education Branch, Office of Policy Communications and EducationNational Center for Advancing Translational Sciences, National Institutes of HealthBethesdaMarylandUSA
| | - Marcus G. Hodges
- Education Branch, Office of Policy Communications and EducationNational Center for Advancing Translational Sciences, National Institutes of HealthBethesdaMarylandUSA
| | - Josh A. Duberman
- National Institutes of Health Library, Office of Research ServicesNational Institutes of HealthBethesdaMarylandUSA
| | - Gisela Butera
- National Institutes of Health Library, Office of Research ServicesNational Institutes of HealthBethesdaMarylandUSA
| | - Jessica M. Faupel‐Badger
- Education Branch, Office of Policy Communications and EducationNational Center for Advancing Translational Sciences, National Institutes of HealthBethesdaMarylandUSA
| |
Collapse
|
2
|
Coussens NP, Sittampalam GS, Guha R, Brimacombe K, Grossman A, Chung TDY, Weidner JR, Riss T, Trask OJ, Auld D, Dahlin JL, Devanaryan V, Foley TL, McGee J, Kahl SD, Kales SC, Arkin M, Baell J, Bejcek B, Gal-Edd N, Glicksman M, Haas JV, Iversen PW, Hoeppner M, Lathrop S, Sayers E, Liu H, Trawick B, McVey J, Lemmon VP, Li Z, McManus O, Minor L, Napper A, Wildey MJ, Pacifici R, Chin WW, Xia M, Xu X, Lal-Nag M, Hall MD, Michael S, Inglese J, Simeonov A, Austin CP. Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery. Clin Transl Sci 2018; 11:461-470. [PMID: 29877628 PMCID: PMC6132369 DOI: 10.1111/cts.12570] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2017] [Accepted: 05/14/2018] [Indexed: 12/30/2022] Open
Abstract
The Assay Guidance Manual (AGM) is an eBook of best practices for the design, development, and implementation of robust assays for early drug discovery. Initiated by pharmaceutical company scientists, the manual provides guidance for designing a “testing funnel” of assays to identify genuine hits using high‐throughput screening (HTS) and advancing them through preclinical development. Combined with a workshop/tutorial component, the overall goal of the AGM is to provide a valuable resource for training translational scientists.
Collapse
Affiliation(s)
- Nathan P Coussens
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - G Sitta Sittampalam
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Rajarshi Guha
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Kyle Brimacombe
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Abigail Grossman
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Thomas D Y Chung
- Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, United States
| | | | - Terry Riss
- Promega Corporation, Madison, Wisconsin, United States
| | - O Joseph Trask
- PerkinElmer, Inc., Waltham, Massachusetts, United States
| | - Douglas Auld
- Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States
| | - Jayme L Dahlin
- Brigham and Women's Hospital, Boston, Massachusetts, United States
| | | | - Timothy L Foley
- Pfizer Worldwide Research and Development, Groton, Connecticut, United States
| | - James McGee
- Eli Lilly and Company, Indianapolis, Indiana, United States
| | - Steven D Kahl
- Eli Lilly and Company, Indianapolis, Indiana, United States
| | - Stephen C Kales
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Michelle Arkin
- Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, California, United States
| | - Jonathan Baell
- Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia
| | - Bruce Bejcek
- Department of Biological Sciences, Western Michigan University, Kalamazoo, Michigan, United States
| | - Neely Gal-Edd
- MacroGenics, Inc., Rockville, Maryland, United States
| | | | - Joseph V Haas
- Eli Lilly and Company, Indianapolis, Indiana, United States
| | | | - Marilu Hoeppner
- National Library of Medicine, National Center for Biotechnology Information, Bethesda, Maryland, United States
| | - Stacy Lathrop
- National Library of Medicine, National Center for Biotechnology Information, Bethesda, Maryland, United States
| | - Eric Sayers
- National Library of Medicine, National Center for Biotechnology Information, Bethesda, Maryland, United States
| | - Hanguan Liu
- National Library of Medicine, National Center for Biotechnology Information, Bethesda, Maryland, United States
| | - Bart Trawick
- National Library of Medicine, National Center for Biotechnology Information, Bethesda, Maryland, United States
| | - Julie McVey
- National Library of Medicine, National Center for Biotechnology Information, Bethesda, Maryland, United States
| | - Vance P Lemmon
- Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida, United States
| | - Zhuyin Li
- Bristol-Myers Squibb, Lead Discovery and Optimization, Princeton, New Jersey, United States
| | - Owen McManus
- Q-State Biosciences, Cambridge, Massachusetts, United States
| | - Lisa Minor
- In Vitro Strategies, LLC, Flemington, New Jersey, United States
| | - Andrew Napper
- FLX Bio, Inc., San Francisco, California, United States
| | - Mary Jo Wildey
- Merck Research Laboratories, Kenilworth, New Jersey, United States
| | - Robert Pacifici
- CHDI Management, Inc./CHDI Foundation, Inc., Los Angeles, California, United States
| | - William W Chin
- Harvard Medical School, Boston, Massachusetts, United States
| | - Menghang Xia
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Xin Xu
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Madhu Lal-Nag
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Matthew D Hall
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Sam Michael
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - James Inglese
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Anton Simeonov
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| | - Christopher P Austin
- National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States
| |
Collapse
|
3
|
Lee G, Kranzler JD, Ramasamy R, Gold-von Simson G. Training scientists as future industry leaders: teaching translational science from an industry executive's perspective. JOURNAL OF TRANSLATIONAL SCIENCE 2018; 4:10.15761/JTS.1000214. [PMID: 29657853 PMCID: PMC5898379 DOI: 10.15761/jts.1000214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
PhDs and post-doctoral biomedical graduates, in greater numbers, are choosing industry based careers. However, most scientists do not have formal training in business strategies and venture creation and may find senior management positions untenable. To fill this training gap, "Biotechnology Industry: Structure and Strategy" was offered at New York University School of Medicine (NYUSOM). The course focuses on the business aspects of translational medicine and research translation and incorporates the practice of business case discussions, mock negotiation, and direct interactions into the didactic. The goal is to teach scientists at an early career stage how to create solutions, whether at the molecular level or via the creation of devices or software, to benefit those with disease. In doing so, young, talented scientists can develop a congruent mindset with biotechnology/industry executives. Our data demonstrates that the course enhances students' knowledge of the biotechnology industry. In turn, these learned skills may further encourage scientists to seek leadership positions in the field. Implementation of similar courses and educational programs will enhance scientists' training and inspire them to become innovative leaders in the discovery and development of therapeutics.
Collapse
Affiliation(s)
- Gloria Lee
- T35 NIDDK Honors Trainee, Clinical and Translational Science Institute, New York University School of Medicine, New York, NY, USA
- State University of New York at Downstate College of Medicine, Brooklyn, NY, USA
| | - Jay D Kranzler
- Department of Medicine, New York University School of Medicine, New York, NY, USA
- New York University Stern School of Business, New York, NY, USA
| | - Ravichandran Ramasamy
- Departments of Medicine, Biochemistry and Molecular Pharmacology, co-PI NIDDK R25, New York University School of Medicine, New York, NY, USA
| | - Gabrielle Gold-von Simson
- Department of Pediatrics, PI NIDDK R25, New York University School of Medicine, New York, NY, USA
- Clinical Translational Science Institute, New York University School of Medicine, New York, NY, USA
| |
Collapse
|